1. Population vulnerability to COVID-19 in Europe: a burden of disease analysis.

Wyper GMA, Assunção R, Cuschieri S, Devleeschauwer B, Fletcher E, Haagsma JA, Hilderink HBM, Idavain J, Lesnik T, Von der Lippe E, Majdan M, Milicevic MS, Pallari E, Peñalvo JL, Pires SM, Plaß D, Santos JV, Stockton DL, Thomsen ST, Grant I.

Arch Public Health. 2020 May 29;78:47. doi: 10.1186/s13690-020-00433-y. eCollection 2020. PMID: 32501409 Free PMC article.

2. High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020.

ECDC Public Health Emergency Team, Danis K, Fonteneau L, Georges S, Daniau C, Bernard-Stoecklin S, Domegan L, O’Donnell J, Hauge SH, Dequeker S, Vandael E, Van der Heyden J, Renard F, Sierra NB, Ricchizzi E, Schweickert B, Schmidt N, Abu Sin M, Eckmanns T, Paiva JA, Schneider E.

Euro Surveill. 2020 Jun;25(22):2000956. doi: 10.2807/1560-7917.ES.2020.25.22.2000956.
PMID: 32524949 Free PMC article.

3. Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020.

Vestergaard LS, Nielsen J, Richter L, Schmid D, Bustos N, Braeye T, Denissov G, Veideman T, Luomala O, Möttönen T, Fouillet A, Caserio-Schönemann C, An der Heiden M, Uphoff H, Lytras T, Gkolfinopoulou K, Paldy A, Domegan L, O’Donnell J, De’ Donato F, Noccioli F, Hoffmann P, Velez T, England K, van Asten L, White RA, Tønnessen R, da Silva SP, Rodrigues AP, Larrauri A, Delgado-Sanz C, Farah A, Galanis I, Junker C, Perisa D, Sinnathamby M, Andrews N, O’Doherty M, Marquess DF, Kennedy S, Olsen SJ, Pebody R; ECDC Public Health Emergency Team for COVID-19, Krause TG, Mølbak K.

Euro Surveill. 2020 Jul;25(26):2001214. doi: 10.2807/1560-7917.ES.2020.25.26.2001214.
PMID: 32643601 Free PMC article.

4. Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.

Catteau L, Dauby N, Montourcy M, Bottieau E, Hautekiet J, Goetghebeur E, van Ierssel S, Duysburgh E, Van Oyen H, Wyndham-Thomas C, Van Beckhoven D; Belgian Collaborative Group on COVID-19 Hospital Surveillance.

Int J Antimicrob Agents. 2020 Oct;56(4):106144. doi: 10.1016/j.ijantimicag.2020.106144. Epub 2020 Aug 24.
PMID: 32853673 Free PMC article.

5. Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients.

Faes C, Abrams S, Van Beckhoven D, Meyfroidt G, Vlieghe E, Hens N; Belgian Collaborative Group on COVID-19 Hospital Surveillance.

Int J Environ Res Public Health. 2020 Oct 17;17(20):7560. doi: 10.3390/ijerph17207560.
PMID: 33080869 Free PMC article.

6. Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis.

de Azambuja E, Brandão M, Wildiers H, Laenen A, Aspeslagh S, Fontaine C, Collignon J, Lybaert W, Verheezen J, Rutten A, Vuylsteke P, Goeminne JC, Demey W, Van Beckhoven D, Deblonde J, Rottey S, Geukens T, Punie K; Belgian Collaborative Group on COVID-19 Hospital Surveillance and the Belgian Society of Medical Oncology (BSMO).

ESMO Open. 2020 Sep;5(5):e000947. doi: 10.1136/esmoopen-2020-000947.
PMID: 32978251 Free PMC article.

7. Valuing the years of life lost due to COVID-19: the differences and pitfalls.

Devleesschauwer B, McDonald SA, Speybroeck N, Wyper GMA.

Int J Public Health. 2020 Jul;65(6):719-720. doi: 10.1007/s00038-020-01430-2. Epub 2020 Jul 20.
PMID: 32691080 Free PMC article. No abstract available.

8. Correction to: Population vulnerability to COVID-19 in Europe: a burden of disease analysis.

Wyper GMA, Assunção R, Cuschieri S, Devleesschauwer B, Fletcher E, Haagsma JA, Hilderink HBM, Idavain J, Lesnik T, Von der Lippe E, Majdan M, Milicevic MS, Pallari E, Peñalvo JL, Pires SM, Plaß D, Santos JV, Stockton DL, Thomsen ST, Grant I.

Arch Public Health. 2020 Jun 18;78:57. doi: 10.1186/s13690-020-00437-8. eCollection 2020.
PMID: 32566224 Free PMC article.

9. Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection.

Gand M, Vanneste K, Thomas I, Van Gucht S, Capron A, Herman P, Roosens NHC, De Keersmaecker SCJ.

Int J Mol Sci. 2020 Aug 4;21(15):5585. doi: 10.3390/ijms21155585.
PMID: 32759818 Free PMC article.

10. Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay.

Mariën J, Ceulemans A, Michiels J, Heyndrickx L, Kerkhof K, Foque N, Widdowson MA, Mortgat L, Duysburgh E, Desombere I, Jansens H, Van Esbroeck M, Ariën KK.

J Virol Methods. 2020 Nov 20:114025. doi: 10.1016/j.jviromet.2020.114025. Online ahead of print.
PMID: 33227340 Free PMC article.